Professor
Radiation Oncology
Dr. Steven J. Dibiase, MD
|
|
Give Review
Steven Dibiase works in the field of Radiation Oncology. He went to Drexel University College of Medicine. He over the years received 2 awards: "Regional Top Doctor" and "Meaningful Use Stage 1 Certification". Dr. Steven J. Dibiase is also published. He has 35 publications published. The lastest publication: "The number of positive margins influences the outcome of women treated with breast preservation for early stage breast carcinoma.' Steven J. Dibiase, MD is registered with Medicare and accepts Medicare payments.
Publications
- Long-Term Results of a Prospective, Phase II Study of Long-term Androgen Ablation, Pelvic Radiotherapy, Brachytherapy Boost, and Adjuvant Docetaxel in Patients with Hi...
- Hypofractionated stereotactic radiotherapy for the treatment of brain metastases.
- Combination external beam radiation and brachytherapy boost with androgen suppression for treatment of intermediate-risk prostate Cancer: an initial report of CALGB 99...
- Factors predicting local tumor control after gamma knife stereotactic radiosurgery for benign intracranial meningiomas.
- Deformable image registration for the use of magnetic resonance spectroscopy in prostate treatment planning.
- Outcome analysis for stage IE and IIE thyroid lymphoma.
- The low alpha/beta ratio for prostate Cancer: what does the clinical outcome of HDR brachytherapy tell us?
- Concomitant boost of stratified target area with gamma knife radiosurgery: a treatment planning study.
- Clinical implementation of an automated planning system for gamma knife radiosurgery.
- Radiosurgical treatment of trigeminal neuralgia: evaluating quality of life and treatment outcomes.
- Stereotactic radiosurgery for benign neoplasms.
- Risk group stratification in patients undergoing permanent (125)I prostate brachytherapy as monotherapy.
- Influence of radiation dose on positive surgical margins in women undergoing breast conservation therapy.
- Influence of gamma knife radiosurgery on the quality of life in patients with brain metastases.
- Magnetic resonance spectroscopic imaging-guided brachytherapy for localized prostate Cancer.
- Gamma knife stereotactic radiosurgery for patients with glioblastoma multiforme.
- Designing equivalent treatment regimens for prostate radiotherapy based on equivalent uniform dose.
- Palliative irradiation for focally symptomatic metastatic renal cell carcinoma: support for dose escalation based on a biological model.
- Tumor bed brachytherapy with a mesh template: an accessible alternative to intraoperative radiotherapy.
- The number of positive margins influences the outcome of women treated with breast preservation for early stage breast carcinoma.
- Uncommon causes of anterior knee pain: a case report of infrapatellar contracture syndrome.
- Repair of DNA double-strand breaks and radiosensitivity to killing in an isogenic group of p53 mutant cell lines.
- The catalytic subunit DNA-dependent protein kinase (DNA-PKcs) facilitates recovery from radiation-induced inhibition of DNA replication.
- Brachytherapy radiation doses to the neurovascular bundles.
- DNA-dependent protein kinase stimulates an independently active, nonhomologous, end-joining apparatus.
- Brachytherapy in patients with small prostate glands.
- Standard off-cord lung oblique fields do not include the entire mediastinum: a computed tomography simulator study.
- Nonhomologous end-joining of ionizing radiation-induced DNA double-stranded breaks in human tumor cells deficient in BRCA1 or BRCA2.
- Radiation necrosis following gamma knife surgery: a case-controlled comparison of treatment parameters and long-term clinical follow up.
- Optimized intensity-modulated arc therapy for prostate Cancer treatment.
- Dose escalation in permanent brachytherapy for prostate Cancer: dosimetric and biological considerations.
- Long-term follow-up of a prospective trial of trimodality therapy of weekly paclitaxel, radiation, and androgen deprivation in high-risk prostate Cancer with or withou...
- Phase I clinical trial assessing temozolomide and tamoxifen with concomitant radiotherapy for treatment of high-grade glioma.
- Dose reconstruction for intensity-modulated radiation therapy using a non-iterative method and portal dose image.
Schools
Drexel University College of Medicine
Albert Einstein Med Center
Thomas Jefferson University Hospital
Conditions Treated
- Vulvar Cancer
Doctors Specialties
- Radiation Oncology
Accepted Insurances
Awards
- Regional Top Doctor
- Meaningful Use Stage 1 Certification
Education
-
Thomas Jefferson University -
Albert Einstein Healthcare Network -
Drexel University College of Medicine
Hospital
-
University of Tennessee Medical Center
Drug Facts
| NPI NUMBER | 1750332292 | |
| NPPES Provider LastName | DIBIASE | |
| NPPES Provider FirstName | STEVEN | |
| NPPES Provider ZIPCode | 080531529 | |
| NPPES Provider State | NJ | |
| Specialty Description | Radiation Oncology | |
| Total Claim Count | 116.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1750332292 |
| Last Name Of The Provider | DIBIASE |
| First Name Of The Provider | STEVEN |
| View All |